TCF-4/TCF7L2 Antibody (YA2167)

Cat. No.: HY-P82422: Data Sheet COA User Guide for Antibodies
FAQs
Technical Support

TCF-4/TCF7L2 Antibody (YA2167) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to TCF-4/TCF7L2.

For research use only. We do not sell to patients.

Size	Stock	Quantity
20 μL	In-stock	Estimated Time of Arrival: December 31
50 μL	In-stock	Estimated Time of Arrival: December 31
100 μL	In-stock	Estimated Time of Arrival: December 31
250 μL	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

TCF-4/TCF7L2 Antibody (YA2167) Featured Recommendations:

WB: Western Blot;
IHC-P: Immunohistochemistry-Paraffin;
IHC-F: Immunohistochemistry-Frozen;
ICC/IF: Immunocytochemistry/Immunofluorescence;
IF-Tissue: Immunofluorescence-Tissue;
mIHC: Multiplex Immunohistochemical;
IP: Immunoprecipitation;
ChIP: Chromatin Immunoprecipitation;
FC: Flow Cytometry;
ELISA: Enzyme Linked Immunosorbent Assay

Product Detail
Background
Documentation

Description

TCF-4/TCF7L2 Antibody (YA2167) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to TCF-4/TCF7L2.

Host

Rabbit

Clonality

Recombinant,Monoclonal

Molecular Weight

Predicted band size: 68 kDa;

Observed band size: 68 kDa

Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.

Species Reactivity

Human

SwissProt ID

Q9NQB0

Gene ID

6934 [NCBI]

Immunogen

A synthetic peptide of human TCF-4 aa2-14.

Application &
Dilution Ratio

Application	Dilution Ratio
WB WB: Western Blot	1:1000-1:5000
IHC	P-1:100-1:200
ICC/IF ICC/IF: Immunocytochemistry/Immunofluorescence	1:100-1:200
FC FC: Flow Cytometry	1:50-1:100

Sensitivity	Endogenous	Purity	Affinity Purified
Conjugation	Non-conjugated	Modification	Unmodified
Isotype	IgG

Appearance

Liquid

Formulation

Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Shipping

Shipping with blue ice.

Background

Function：Participates in the Wnt signaling pathway and modulates MYC expression by binding to its promoter in a sequence-specific manner. Acts as a repressor in the absence of CTNNB1, and as activator in its presence. Activates transcription from promoters with several copies of the Tcf motif 5'-CCTTTGATC-3' in the presence of CTNNB1. TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by TCF7L2/TCF4 and CTNNB1. Expression of dominant-negative mutants results in cell-cycle arrest in G1. Necessary for the maintenance of the epithelial stem-cell compartment of the small intestine

Subcellular Localization：Nucleus, PML body; Nucleus

Expression：
Tissue_specificity:This gene was detected in small intestinal epithelial cells, with the highest expression at the top of the crypts and a gradient of expression from the crypts to the villi. It was also detected in colonic epithelial cells and colon cancer, as well as in breast epithelial cells and their derivative carcinomas.

Isoforms & Post-Translational Modification：Q9NQB0 has 17 isomers: Q9NQB0-1: 67919 Da (predicted); Q9NQB0-2: 55152 Da (predicted); Q9NQB0-3: 67976 Da (predicted); Q9NQB0-4: 53270 Da (predicted); Q9NQB0-5: 66037 Da (predicted); Q9NQB0-6: 53676 Da (predicted); Q9NQB0-7: 66094 Da (predicted); Q9NQB0-8: 65291 Da (predicted); Q9NQB0-9: 51794 Da (predicted); Q9NQB0-10: 50611 Da (predicted); Q9NQB0-11: 54572 Da (predicted); Q9NQB0-12: 51159 Da (predicted); Q9NQB0-13: 63466 Da (predicted); Q9NQB0-14: 49166 Da (predicted); Q9NQB0-15: 49688 Da (predicted); Q9NQB0-16: 63930 Da (predicted); Q9NQB0-17: 36884 Da (predicted).
In vitro, phosphorylated by TNIK;Phosphorylated at Thr-201 and/or Thr-212 by NLK. Phosphorylation by NLK at these sites inhibits DNA-binding by TCF7L2/TCF4, thereby preventing transcriptional activation of target genes of the canonical Wnt/beta-catenin signaling pathway;Polysumoylated. Sumoylation is enhanced by PIAS family members and desumoylation is enhanced by SENP2. Sumoylation/desumoylation regulates TCF7L2/TCF4 transcription activity in the Wnt/beta-catenin signaling pathway without altering interaction with CTNNB1 nor binding to DNA

Subunit：Interacts with TGFB1I1 (By similarity). Interacts with CTNNB1 (via the armadillo repeat); forms stable transcription complex (PubMed:10080941, PubMed:17052462, PubMed:19816403, PubMed:28829046, PubMed:29739711, PubMed:9065401, PubMed:9916915). Interacts with EP300. Interacts with NLK. Interacts with CCDC85B (probably through the HMG box); prevents interaction with CTNNB1. Interacts with TNIK. Interacts with MAD2L2; prevents TCF7L2/TCF4 binding to promZIPK/DAPK3oters, negatively modulating its transcriptional activity. Interacts with ZIPK/DAPK3. Interacts with XIAP/BIRC4 and TLE3. Interacts with DDIT3/CHOP. The CTNNB1 and TCF7L2/TCF4 complex interacts with PML (isoform PML-4). Identified in a complex with CTNNB1 and FERMT2. Interacts with SPIN1 (PubMed:22258766, PubMed:24589551, PubMed:29061846). Interacts with C11orf84/SPINDOC in a SPIN1-dependent manner (PubMed:29061846). Interacts with DAZAP2; the interaction results in localization of DAZAP2 to the nucleus (PubMed:19304756)

Database

Entrez Gene: 6934 Human

SwissProt: Q9NQB0 Human

OMIM: 125853 Human

Research Field

Epigenetics and Nuclear Signaling

Synonyms

TCF7L2; HMG box transcription factor 4; HTCF-4; T-cell factor-4 variant X2; T-cell factor 4; Transcription factor 7-like 2; TCF-4

Documentation

Select Batch:

COA (206 KB)

User Guide for Antibodies (1077 KB)

TCF-4/TCF7L2 Antibody (YA2167) Related Classifications

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Product Name

Requested Quantity *

Applicant Name *

Salutation

Email Address *

Phone Number *

Department

Organization Name *

City

State

Country or Region *

Remarks

Product Name

Lot #

Applicant Name *

Country or Region *

Email Address *

Remarks

Name
Email *

	Sorry, but the email address you supplied was invalid.

TCF-4/TCF7L2 Antibody (YA2167)

TCF-4/TCF7L2 Antibody (YA2167) Featured Recommendations:

Product Detail

Background

Documentation

TCF-4/TCF7L2 Antibody (YA2167) Related Classifications

Your Recently Viewed Products:

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report